Lastest Stories by Jon C. Ogg

Here are eight secondary offerings that have been filed with a grand tally of about $3 billion combined.
The Bureau of Labor Statistics probably has at least some good insight into the jobs market. That said, it has to be a hard guess in making a forecast for the next decade.
Of the 30 or so regional and mid-cap banks covered in a new Wedbush report, only these were named as the top picks with ample upside.
The top analyst upgrades, downgrades and initiations for Wednesday included AbbVie, Camping World, Cleveland-Cliffs, Coupa Software, Dollar General, DuPont, Nike, Roku and StoneCo.
24/7 Wall St. has put together a list of eight alternatives for Treasury and traditional bonds investors who must have income to help supplement their lives.
Colgate-Palmolive is a highly defensive stock, despite being in the crowded and competitive field of consumer products. But is it cheap?
For those investors and technology fans who were hoping for a rapid rebound in the global semiconductor market, it seems as though the hope is going to have to take a backseat to reality. The...
The Institute for Supply Management reported a disappointing turn in economic activity in the manufacturing sector during the month of August.
On top of the company announcing an acquisition on Tuesday, Vertex has seen a substantial analyst upgrade from Goldman Sachs.
Credit Suisse's U.S. equity strategy team has made significant changes to its underlying U.S. equity sector weightings that are intended to better align with the firm's near-term cautious outlook.
The top analyst upgrades, downgrades and initiations for Tuesday included Annaly Capital Management, Amazon.com, Enterprise Products Partners, Kinder Morgan, Lululemon Athletica, RealReal, Snap,...
The last week of August proved to be one in which the salvos in the trade war between the United States and China took a breather.
The top analyst upgrades, downgrades and initiations for Friday included Abercrombie, Ambarella, Best Buy, Dollar General, Novo Nordisk, Ulta Beauty and Whiting Petroleum.
It’s not unusual for management changes to be announced in Corporate America. In fact, some companies rotate in and out of senior management as if the company is a ride in a theme park. And then...
Mallinckrodt is a pharmaceutical player that has been in trouble over its role in the opioid crisis in America. Investors have to wonder if the worst outcome is in the making.